COVID-19: DCGI approves Serum Institute to manufacture Sputnik V vaccine in India

SII has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V.

from Latest News https://ift.tt/3cjc4bE